Cargando…

RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma

Tumor suppressor genes and the immune system are critical players in inhibiting cancer initiation and/or progression. However, little is known about whether a tumor suppressor gene can function through both immune-dependent and -independent mechanisms. Retinoic acid receptor responder 2 (RARRES2) is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu-Chittenden, Yi, Jain, Meenu, Gaskins, Kelli, Wang, Sophie, Merino, Maria J., Kotian, Shweta, Gara, Sudheer Kumar, Davis, Sean, Zhang, Lisa, Kebebew, Electron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481486/ https://www.ncbi.nlm.nih.gov/pubmed/28114280 http://dx.doi.org/10.1038/onc.2016.497

Ejemplares similares

Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples
por: Gara, Sudheer Kumar, et al.
Publicado: (2015)

GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
por: Gara, Sudheer Kumar, et al.
Publicado: (2020)

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
por: Nilubol, Naris, et al.
Publicado: (2018)

Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
por: Gara, Sudheer Kumar, et al.
Publicado: (2018)

Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma
por: Liu-Chittenden, Yi, et al.
Publicado: (2015)

To the editor
por: Kebebew, Electron, et al.
Publicado: (2017)

Adrenocortical Carcinoma and Synchronous Malignancies
por: Guerrero, Marlon A., et al.
Publicado: (2010)

miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2015)

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019)

KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer
por: Jain, Meenu, et al.
Publicado: (2011)

The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells
por: Anderson, Alison M., et al.
Publicado: (2017)

Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2019)

2261 Tumor suppressor RARRES1 regulates cell survival by modulating mitochondrial energetics
por: Maimouni, Sara, et al.
Publicado: (2018)

NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer
por: Orois, Aida, et al.
Publicado: (2019)

Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
por: Maimouni, Sara, et al.
Publicado: (2018)

Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2021)

ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195
por: Jain, Meenu, et al.
Publicado: (2014)

β→LACTAMASE-PRODUCING ANAEROBES
por: Reilly, Sheena, et al.
Publicado: (1980)

Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
por: Nilubol, Naris, et al.
Publicado: (2012)

Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN
por: Oldridge, E E, et al.
Publicado: (2013)

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study
por: Aswath, Kshama, et al.
Publicado: (2021)

Examination of effects of GSK3β phosphorylation, β-catenin phosphorylation, and β-catenin degradation on kinetics of Wnt signaling pathway using computational method
por: Sun, Ying-Chieh
Publicado: (2009)

β-Catenin Phosphorylated at Serine 45 Is Spatially Uncoupled from β-Catenin Phosphorylated in the GSK3 Domain: Implications for Signaling
por: Maher, Meghan T., et al.
Publicado: (2010)

Phosphorylation Reduces the Mechanical Stability of the α‐Catenin/ β‐Catenin Complex
por: Le, Shimin, et al.
Publicado: (2019)

Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation
por: Enomoto, Atsushi, et al.
Publicado: (2019)

Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26
por: Sahab, Ziad J., et al.
Publicado: (2010)

Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
por: Shah, Kinjal, et al.
Publicado: (2022)

Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1
por: Coyle, Krysta M., et al.
Publicado: (2016)

Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature
por: Neychev, Vladimir, et al.
Publicado: (2017)

Chronic tooth pulp inflammation induces persistent expression of phosphorylated ERK (pERK) and phosphorylated p38 (pp38) in trigeminal subnucleus caudalis
por: Worsley, M.A., et al.
Publicado: (2014)

Inhibition of GSK3 Phosphorylation of β-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6
por: Wu, Geng, et al.
Publicado: (2009)

Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling
por: He, Yongfeng, et al.
Publicado: (2016)

The Menin Tumor Suppressor Protein Is Phosphorylated in Response to DNA Damage
por: Francis, Joshua, et al.
Publicado: (2011)

Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
por: Narasimha, Anil M, et al.
Publicado: (2014)

Phosphorylation of Suppressor of Hairless impedes its DNA-binding activity
por: Nagel, Anja C., et al.
Publicado: (2017)

Phosphorylated resveratrol as a protein aggregation suppressor in vitro and in vivo
por: Mehringer, Johannes, et al.
Publicado: (2022)

Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer.
por: Takayama, T., et al.
Publicado: (1998)

Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models
por: Lepore Signorile, Martina, et al.
Publicado: (2023)

Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
por: Habra, Mouhammed Amir, et al.
Publicado: (2021)

Synthetic Phosphorylation of p38α Recapitulates Protein Kinase Activity
por: Chooi, K. Phin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n6pbfvl7jpf2brgs61eq1h6lf5